SCHEMBL2491627

SCHEMBL2491627

C=CCCCCCCCCCCCCCCC=CC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.58
ABCC4 O15439 1/20 0.58
TBXAS1 P24557 3/20 0.46
PTPN1 P18031 1/20 0.46
LMNA P02545 3/20 0.45
ALDH1A1 P00352 2/20 0.45
USP2 O75604 1/20 0.43
CYP3A4 P08684 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GABRR1 P24046 2/20 0.42
GABRR2 P28476 2/20 0.42
BLM P54132 2/20 0.42
TSHR P16473 2/20 0.42
GABRR3 A8MPY1 1/20 0.42
APEX1 P27695 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
LPAR2 Q9HBW0 1/20 0.41
LPAR3 Q9UBY5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27896983 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL9281262 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL27957677 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL2854551 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL5378939 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL5378935 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL2854557 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL15284588 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL9735318 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA
SCHEMBL9955539 1.00 MAPT (0.58) MAPTABCC4TBXAS1PTPN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4692226-A1 SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION Kuraray Co., Ltd. (JP) 2026-02-11 EP disclosed
EP-4674910-A1 COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER Kuraray Co., Ltd. (JP) 2026-01-07 EP disclosed
WO-2024210066-A1 SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION 株式会社クラレ 2024-10-10 WO disclosed
WO-2024181532-A1 COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER 株式会社クラレ 2024-09-06 WO disclosed
WO-2023182120-A1 DISPERSION AND LUBRICANT COMPOSITION DIC株式会社 2023-09-28 WO disclosed
US-20200138695-A1 COSMETIC COMPOSITION ROHTO PHARMACEUTICAL CO., LTD. (JP) 2020-05-07 US disclosed
EP-3616683-A1 COSMETIC COMPOSITION Rohto Pharmaceutical Co., Ltd. (JP) 2020-03-04 EP disclosed
CN-110621295-A Cosmetic composition 日本乐敦制药株式会社 2019-12-27 CN disclosed
US-9102774-B2 Polymers derived from secondary alkyl (meth)acrylates 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-11 US disclosed
EP-2655451-B1 POLYMERS DERIVED FROM SECONDARY ALKYL (METH)ACRYLATES 3M INNOVATIVE PROPERTIES CO (US) 2015-03-11 EP disclosed
US-7488841-B2 Composition containing acyl group ASAHI KASEI CHEMICALS CORPORATION (JP) 2009-02-10 US disclosed
CN-101198309-A Composition for protection of body surface ASAHI CHEMICAL CORP (JP) 2008-06-11 CN disclosed
EP-1891924-A1 COMPOSITION FOR PROTECTION OF BODY SURFACE Asahi Kasei Chemicals Corporation (JP) 2008-02-27 EP disclosed
US-20050265951-A1 Novel composition containing acyl group ASAHI KASEI KABUSHIKI KAISHA (JP) 2005-12-01 US disclosed
EP-1547998-A1 NOVEL COMPOSITION CONTAINING ACYL GROUP Asahi Kasei Chemicals Corporation (JP) 2005-06-29 EP disclosed
US-6569829-B1 Removing impurities from a long chain N-acyl acidic amino acid such as N-lauroyl-L-glutamic acid containing an inorganic salt by solvent extraction using a solution of water and tert-butanol; use in cosmetics and detergents ASAHI KASEI KABUSHIKI KAISHA (JP) 2003-05-27 US disclosed
EP-1156033-A1 PROCESS FOR PRODUCING ACIDIC N-(LONG-CHAIN ACYL)AMINO ACID Asahi Kasei Kabushiki Kaisha (JP) 2001-11-21 EP disclosed
EP-0413305-B1 Chlorosulfonated polyethylene polymer composition TOSOH CORP (JP) 1998-04-08 EP disclosed
US-5344861-A Polymer blend with organic acid, phenylamine, phenylenediamine and acid acceptor with vulcanization agent TOSOH CORPORATION (JP) 1994-09-06 US disclosed
EP-0413305-A1 Chlorosulfonated polyethylene polymer composition TOSOH CORPORATION (JP) 1991-02-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200138695-A1 COSMETIC COMPOSITION CUTA, LAGE3, SMURF1 MAPT 1496/4885ABCC4 4627/4885TBXAS1 4032/4885
US-20050265951-A1 Novel composition containing acyl group AADAC, ACADM, ADCK5 MAPT 2834/4885ABCC4 3091/4885TBXAS1 2931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.